ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Astellas Completes Acquisition of Audentes Therapeutics
January 16, 2020Astellas Pharma has successfully completed the previously announced acquisition of Audentes Therapeutics, through a tender offer by its indirect wholly-owned subsidiary Asilomar Acquisition for all of the issued and outstanding shares of common stock of . -
Astellas enters into definitive agreement to acquire Audentes Therapeutics
December 10, 2019Astellas has announced that it will be acquiring Audentes Therapeutics at a total cost of $3 billion.
Pharma Sources Insight January 2025
